Does Glp-2 have a protective effect on cerebral ischemia/reperfusion model?

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Cerebral ischemia/reperfusion (I/R) injury causes significant damage to the hippocampus.
• Oxidative stress, indicated by malondialdehyde (MDA) and myeloperoxidase (MPO) activity, is a key factor in I/R-induced neuronal damage.
• Glucagon-like peptide 2 (Glp-2) is known to increase cerebral blood flow, suggesting potential neuroprotective properties.

Purpose of the Study:

• To investigate the neuroprotective effects of Glp-2 on the hippocampus after cerebral I/R injury in a rat model.
• To evaluate Glp-2's impact on oxidative stress markers and cell apoptosis in the hippocampal complex.

Main Methods:

• Rats were subjected to 40 minutes of bilateral internal carotid artery occlusion followed by 6 hours of reperfusion.
• Animals were divided into four groups: sham, I/R + saline, I/R + pre-ischemia Glp-2, and I/R + post-ischemia Glp-2.
• Hippocampal tissues were analyzed for MDA, glutathione (GSH), and MPO levels, along with histopathological assessment of cell apoptosis.

Main Results:

• I/R injury significantly increased MDA levels and MPO activity, and the number of apoptotic cells in hippocampal tissue.
• Glp-2 administration (both pre- and post-ischemia) significantly reduced MDA levels, MPO activity, and apoptotic cell counts compared to the I/R + saline group.
• Glutathione (GSH) levels did not show significant differences among the groups.

Conclusions:

• Glp-2 treatment demonstrates significant neuroprotective effects against cerebral I/R injury in rats.
• Glp-2 may mitigate I/R-induced oxidative damage and apoptosis in the hippocampal complex.
• These findings suggest Glp-2 as a potential therapeutic agent for conditions involving cerebral ischemia.